advanced gastric cancer
Showing 1 - 25 of 61
HER2-overexpressed Advanced Solid Tumors After Progression of
Not yet recruiting
- HER2
- +3 more
- Disitamab Vedotin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Dec 14, 2022
Advanced Gastric Cancer Trial in Seoul (Intergrate early palliatuve care + Conventional chemo, Conventional chemo)
Recruiting
- Advanced Gastric Cancer
- Intergrate early palliatuve care + Conventional chemotherapy
- Conventional chemotherapy
-
Seoul, Korea, Republic ofYonsei Cancer Center, Yonsei University College of Medicine
Oct 17, 2022
Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)
Active, not recruiting
- Advanced Gastric Cancer
- Nivolumab
- +4 more
-
Phoenix, Arizona
- +34 more
Aug 18, 2022
Advanced Gastric Cancer Trial in China (fruquintinib +paclitaxel, fruquintinib + paclitaxel)
Active, not recruiting
- Advanced Gastric Cancer
- fruquintinib +paclitaxel
- fruquintinib placebo + paclitaxel
-
Hefei, Anhui, China
- +6 more
Aug 16, 2022
Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)
Recruiting
- Advanced Gastric Cancer
- Transcatheter Arterial Chemoembolization
- Tislelizumab
-
Shanghai, Shanghai, ChinaZhongShan hospital Fudan university
May 25, 2022
Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)
Recruiting
- Advanced Hepatocellular Carcinoma
- +3 more
- EPCAM CAR-T
-
Hangzhou, ChinaFirst affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022
Advanced Gastric Cancer Trial in Seoul (Paclitaxel, Olaparib, Durvalumab)
Active, not recruiting
- Advanced Gastric Cancer
- Paclitaxel
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 22, 2021
Advanced Gastric Cancer, Advanced Gastroesophageal Junction Adenocarcinoma Trial in Wuhan (PD-1 inhibitor(Tislelizumab)
Recruiting
- Advanced Gastric Cancer
- Advanced Gastroesophageal Junction Adenocarcinoma
- PD-1 inhibitor(Tislelizumab) ,SOX(S-1+ Oxaliplatin)
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College of HUST
Aug 4, 2021
Advanced Gastric Cancer, Peritoneal Carcinomatosis Trial in Seoul (1. Treatment: IP chemo + Systemic chemo, 2. Response
Recruiting
- Advanced Gastric Cancer
- Peritoneal Carcinomatosis
- 1. Treatment: IP chemotherapy + Systemic chemotherapy
- 2. Response evaluation after 4 cycles of IP + systemic chemotherapy
-
Seoul, Gangnnam, Korea, Republic ofGangnam Severacne Hospital
Mar 11, 2021
Advanced Gastric Cancer, Gastro-esophageal Junction Cancer Trial in Worldwide (AUY922, Docetaxel, Irinotecan)
Completed
- Advanced Gastric Cancer
- Gastro-esophageal Junction Cancer
- AUY922
- +2 more
-
Los Angeles, California
- +35 more
Dec 8, 2020
Advanced Gastric Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer,
Withdrawn
- Advanced Gastric Cancer
- Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Gastric cancer
- Cryotherapy
-
Guangzhou, Guangdong, ChinaInstitutional Review Board of Guangzhou Fuda Cancer Hospital
Oct 13, 2020
Advanced Gastric Cancer Trial in Fuzhou (Camrelizumab, Apatinib Mesylate, nab-paclitaxel)
Recruiting
- Advanced Gastric Cancer
- Camrelizumab
- +3 more
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Jun 3, 2020
Advanced Gastric Cancer, Gastroesophageal Cancer Trial in Zibo (Cell infusion for Dose-finding (Group A), Cell infusion for
Recruiting
- Advanced Gastric Cancer
- Gastroesophageal Cancer
- Cell infusion for Dose-finding (Group A)
- Cell infusion for Extended research (Group B)
-
Zibo, ChinaChangguo hospital of Zibo
May 9, 2020
Advanced Gastric Cancer Trial in Shenyang (Albumin-paclitaxel, Apatinib, Camrelizumab)
Unknown status
- Advanced Gastric Cancer
- Albumin-paclitaxel, Apatinib, Camrelizumab
-
Shenyang, Liaoning, ChinaThe First Hospital of China Medical University
Feb 25, 2020
Advanced Gastric Cancer, Esophagogastric Junction Cancer Trial in Frankfurt/Main (Paclitaxel, RAD001)
Completed
- Advanced Gastric Cancer
- Esophagogastric Junction Cancer
-
Frankfurt/Main, GermanyKrankenhaus Nordwest
Jan 27, 2020
Advanced Gastric Cancer Trial in Seoul (Capecitabine, Cisplatin, Sorafenib)
Completed
- Advanced Gastric Cancer
- Capecitabine, Cisplatin, Sorafenib
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 6, 2020
Advanced Gastric Cancer Trial in Seoul (RAD001, Capecitabine, Oxaliplatin)
Completed
- Advanced Gastric Cancer
- RAD001, Capecitabine, Oxaliplatin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020
Advanced Gastric Cancer Trial in Seoul (Docetaxel, Capecitabine, Cisplatin, Bevacizumab)
Completed
- Advanced Gastric Cancer
- Docetaxel, Capecitabine, Cisplatin, Bevacizumab
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 6, 2020
Venous Thromboembolism in Advanced Gastric Cancer Patients
Completed
- Advanced Gastric Cancer
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020
Advanced Gastric Cancer Trial in Seoul (S-1 and cisplatin)
Completed
- Advanced Gastric Cancer
- S-1 and cisplatin
-
Seoul, Korea, Republic ofDepartment of Oncology, Asan Medical Center
Jan 6, 2020
Advanced Gastric Cancer Trial in Seoul (oxaliplatin, 5-fluorouracil)
Completed
- Advanced Gastric Cancer
- oxaliplatin, 5-fluorouracil
-
Seoul, Korea, Republic ofAsan medical center
Jan 6, 2020
Advanced Gastric Cancer Trial in Seoul (AZD5363, paclitaxel)
Completed
- Advanced Gastric Cancer
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Dec 26, 2019